{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T04:00:44Z","timestamp":1747108844746,"version":"3.40.5"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,11]]},"DOI":"10.7759\/cureus.83936","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T06:52:26Z","timestamp":1747032746000},"source":"Crossref","is-referenced-by-count":0,"title":["A Case of Sarcoidosis Diagnosed Based on Progressive Renal Dysfunction and Lymphadenopathy"],"prefix":"10.7759","author":[{"given":"Tomohide","family":"Sato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12888-7","article-title":"Sarcoidosis","volume":"361","author":"Baughman RP","year":"2003","unstructured":"Baughman RP, Lower EE, du Bois RM. Sarcoidosis. Lancet. 2003, 361:1111-8. 10.1016\/S0140-6736(03)12888-7","journal-title":"Lancet"},{"key":"ref2","article-title":"Current concepts of the pathogenesis of sarcoidosis","volume":"135","author":"Thomas PD","year":"1987","unstructured":"Thomas PD, Hunninghake GW. Current concepts of the pathogenesis of sarcoidosis. Am Rev Respir Dis. 1987, 135:747-60.","journal-title":"Am Rev Respir Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V391555","article-title":"The kidney in sarcoidosis","volume":"3","author":"Casella FJ","year":"1993","unstructured":"Casella FJ, Allon M. The kidney in sarcoidosis. J Am Soc Nephrol. 1993, 3:1555-62. 10.1681\/ASN.V391555","journal-title":"J Am Soc Nephrol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201511-760OC","article-title":"Sarcoidosis in America. Analysis based on health care use","volume":"13","author":"Baughman RP","year":"2016","unstructured":"Baughman RP, Field S, Costabel U, et al.. Sarcoidosis in America. Analysis based on health care use. Ann Am Thorac Soc. 2016, 13:1244-52. 10.1513\/AnnalsATS.201511-760OC","journal-title":"Ann Am Thorac Soc"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/MCP.0000000000000715","article-title":"Sarcoidosis epidemiology: recent estimates of incidence, prevalence and risk factors","volume":"26","author":"Arkema EV","year":"2020","unstructured":"Arkema EV, Cozier YC. Sarcoidosis epidemiology: recent estimates of incidence, prevalence and risk factors. Curr Opin Pulm Med. 2020, 26:527-34. 10.1097\/MCP.0000000000000715","journal-title":"Curr Opin Pulm Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00477-2016","article-title":"Sarcoidosis incidence and prevalence: a nationwide register-based assessment in Sweden","volume":"48","author":"Arkema EV","year":"2016","unstructured":"Arkema EV, Grunewald J, Kullberg S, Eklund A, Askling J. Sarcoidosis incidence and prevalence: a nationwide register-based assessment in Sweden. Eur Respir J. 2016, 48:1690-9. 10.1183\/13993003.00477-2016","journal-title":"Eur Respir J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00444-2019","article-title":"Epidemiology and health outcomes of sarcoidosis in a universal healthcare population: a cohort study","volume":"54","author":"Fidler LM","year":"2019","unstructured":"Fidler LM, Balter M, Fisher JH, et al.. Epidemiology and health outcomes of sarcoidosis in a universal healthcare population: a cohort study. Eur Respir J. 2019, 54:10.1183\/13993003.00444-2019","journal-title":"Eur Respir J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2015.10.024","article-title":"Epidemiology of sarcoidosis 1946-2013: a population-based study","volume":"91","author":"Ungprasert P","year":"2016","unstructured":"Ungprasert P, Carmona EM, Utz JP, et al.. Epidemiology of sarcoidosis 1946-2013: a population-based study. Mayo Clin Proc. 2016, 91:183-8. 10.1016\/j.mayocp.2015.10.024","journal-title":"Mayo Clin Proc"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-016-9952-6","article-title":"Influence of gender on epidemiology and clinical manifestations of sarcoidosis: a population-based retrospective cohort study 1976-2013","volume":"195","author":"Ungprasert P","year":"2017","unstructured":"Ungprasert P, Crowson CS, Matteson EL. Influence of gender on epidemiology and clinical manifestations of sarcoidosis: a population-based retrospective cohort study 1976-2013. Lung. 2017, 195:87-91. 10.1007\/s00408-016-9952-6","journal-title":"Lung"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-27554-3","article-title":"Nationwide survey on the organ-specific prevalence and its interaction with sarcoidosis in Japan","volume":"8","author":"Hattori T","year":"2018","unstructured":"Hattori T, Konno S, Shijubo N, et al.. Nationwide survey on the organ-specific prevalence and its interaction with sarcoidosis in Japan. Sci Rep. 2018, 8:9440. 10.1038\/s41598-018-27554-3","journal-title":"Sci Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.164.10.2104046","article-title":"Clinical characteristics of patients in a case control study of sarcoidosis","volume":"164","author":"Baughman RP","year":"2001","unstructured":"Baughman RP, Teirstein AS, Judson MA, et al.. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. 2001, 164:1885-9. 10.1164\/ajrccm.164.10.2104046","journal-title":"Am J Respir Crit Care Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000007595","article-title":"Multidisciplinary approach and long-term follow-up in a series of 640 consecutive patients with sarcoidosis: Cohort study of a 40-year clinical experience at a tertiary referral center in Barcelona, Spain","volume":"96","author":"Ma\u00f1\u00e1 J","year":"2017","unstructured":"Ma\u00f1\u00e1 J, Rubio-Rivas M, Villalba N, et al.. Multidisciplinary approach and long-term follow-up in a series of 640 consecutive patients with sarcoidosis: Cohort study of a 40-year clinical experience at a tertiary referral center in Barcelona, Spain. Medicine (Baltimore). 2017, 96:e7595. 10.1097\/MD.0000000000007595","journal-title":"Medicine (Baltimore)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01443","article-title":"Biomarkers in the diagnosis and prognosis of sarcoidosis: current use and future prospects","volume":"11","author":"Kraaijvanger R","year":"2020","unstructured":"Kraaijvanger R, Janssen Bon\u00e1s M, Vorselaars AD, Veltkamp M. Biomarkers in the diagnosis and prognosis of sarcoidosis: current use and future prospects. Front Immunol. 2020, 11:1443. 10.3389\/fimmu.2020.01443","journal-title":"Front Immunol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2004.04.006","article-title":"Pulmonary sarcoidosis","volume":"25","author":"Baughman RP","year":"2004","unstructured":"Baughman RP. Pulmonary sarcoidosis. Clin Chest Med. 2004, 25:521-30, vi. 10.1016\/j.ccm.2004.04.006","journal-title":"Clin Chest Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1177\/000456328902600102","article-title":"Serum angiotensin converting enzyme in sarcoidosis--its value in present clinical practice","volume":"26 ( Pt 1)","author":"Studdy PR","year":"1989","unstructured":"Studdy PR, Bird R. Serum angiotensin converting enzyme in sarcoidosis--its value in present clinical practice. Ann Clin Biochem. 1989, 26 ( Pt 1):13-8. 10.1177\/000456328902600102","journal-title":"Ann Clin Biochem"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-015-9826-3","article-title":"Diagnostic utility of angiotensin-converting enzyme in sarcoidosis: a population-based study","volume":"194","author":"Ungprasert P","year":"2016","unstructured":"Ungprasert P, Carmona EM, Crowson CS, Matteson EL. Diagnostic utility of angiotensin-converting enzyme in sarcoidosis: a population-based study. Lung. 2016, 194:91-5. 10.1007\/s00408-015-9826-3","journal-title":"Lung"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/9785957","article-title":"Retracted: diagnostic and staging value of serum angiotensin-converting enzyme in sarcoidosis","volume":"2023","author":"Methods In Medicine CA","year":"2023","unstructured":"Methods In Medicine CA. Retracted: diagnostic and staging value of serum angiotensin-converting enzyme in sarcoidosis. Comput Math Methods Med. 2023, 2023:9785957. 10.1155\/2023\/9785957","journal-title":"Comput Math Methods Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1378\/chest.124.1.186","article-title":"Serum soluble interleukin-2 receptor measurement in patients with sarcoidosis: a clinical evaluation","volume":"124","author":"Grutters JC","year":"2003","unstructured":"Grutters JC, Fellrath JM, Mulder L, et al.. Serum soluble interleukin-2 receptor measurement in patients with sarcoidosis: a clinical evaluation. Chest. 2003, 124:186-95. 10.1378\/chest.124.1.186","journal-title":"Chest"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/8565423","article-title":"Prognostic biomarkers of sarcoidosis: a comparative study of serum chitotriosidase, ACE, lysozyme, and KL-6","volume":"2019","author":"Bergantini L","year":"2019","unstructured":"Bergantini L, Bianchi F, Cameli P, et al.. Prognostic biomarkers of sarcoidosis: a comparative study of serum chitotriosidase, ACE, lysozyme, and KL-6. Dis Markers. 2019, 2019:8565423. 10.1155\/2019\/8565423","journal-title":"Dis Markers"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/pl00007637","article-title":"Serum lysozyme levels and clinical features of sarcoidosis","volume":"177","author":"Tomita H","year":"1999","unstructured":"Tomita H, Sato S, Matsuda R, et al.. Serum lysozyme levels and clinical features of sarcoidosis. Lung. 1999, 177:161-7. 10.1007\/pl00007637","journal-title":"Lung"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e31819de50f","article-title":"Renal sarcoidosis: clinical, laboratory, and histologic presentation and outcome in 47 patients","volume":"88","author":"Mah\u00e9vas M","year":"2009","unstructured":"Mah\u00e9vas M, Lescure FX, Boffa JJ, et al.. Renal sarcoidosis: clinical, laboratory, and histologic presentation and outcome in 47 patients. Medicine (Baltimore). 2009, 88:98-106. 10.1097\/MD.0b013e31819de50f","journal-title":"Medicine (Baltimore)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/315547-a-case-of-sarcoidosis-diagnosed-based-on-progressive-renal-dysfunction-and-lymphadenopathy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T06:52:27Z","timestamp":1747032747000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/315547-a-case-of-sarcoidosis-diagnosed-based-on-progressive-renal-dysfunction-and-lymphadenopathy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,11]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.83936","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,11]]}}}